SCHEMBL8355292

SCHEMBL8355292

COc1ccc(CC2(S(=O)(=O)NC(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.41
CA1 P00915 3/20 0.41
CA14 Q9ULX7 2/20 0.41
CA7 P43166 1/20 0.41
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 1/20 0.40
STS P08842 1/20 0.39
CACNA1B Q00975 2/20 0.39
PTPRB P23467 1/20 0.39
MMP9 P14780 2/20 0.38
MMP13 P45452 2/20 0.38
EGFR P00533 2/20 0.38
ERBB2 P04626 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
CA2 P00918 3/20 0.38
CA9 Q16790 2/20 0.38
MMP1 P03956 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8354955 0.86 CA1 (0.42) CA12CA1CA14CA7ALDH1A1
SCHEMBL6124818 0.86 CACNA1B (0.41) CA12CA1CA14CA7PPARG
SCHEMBL8290203 0.77 CA12 (0.46) CA12CA1CA14CA7PPARG
SCHEMBL4977511 0.76 ALDH1A1 (0.40) ALDH1A1KMT2AMMP9MMP13EGFR
SCHEMBL26388338 0.75 PPARG (0.42) PPARGPPARAALDH1A1KMT2ACACNA1B
SCHEMBL25736271 0.75 TDP1 (0.43) CA12CA1CA14CA7KMT2A
SCHEMBL8354526 0.75 CA12 (0.43) CA12CA1CA14CA7CA2
SCHEMBL8356015 0.75 CA12 (0.43) CA12CA1CA14CA7ALDH1A1
SCHEMBL7815313 0.74 CA12 (0.45) CA12CA1CA14CA7KMT2A
SCHEMBL12396882 0.74 CA12 (0.49) CA12CA1CA14CA7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004043339-A2 SUBSTITUTED CYCLOALKYL P1' HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-05-27 WO disclosed